Posts

Posted on

Onychorrhexis

Onychorrhexis is a nail condition marked by vertical ridging and splitting of the nail plate, most often affecting the fingernails but sometimes the toenails as well. It is usually harmless and cosmetic, but it can also signal an underlying health issue or repeated nail damage.

What it is

The word onychorrhexis comes from Greek roots meaning “nail” and “bursting,” which fits the way the nail can look brittle and fractured. In simple terms, the nail grows with fine longitudinal grooves, may feel rough, and can break or peel more easily than normal. The condition is part of the broader group of brittle nail disorders, and clinicians often use it to describe the pattern of vertical ridging and splitting.

Causes and risk factors

Onychorrhexis can happen for many reasons, and aging is one of the most common. It may also be linked to repeated wetting and drying of the hands, frequent use of nail polish remover, nail biting or picking, and other external trauma to the nail plate. Nutritional problems and medical conditions such as iron-deficiency anemia, thyroid disease, eating disorders, fungal infection, psoriasis, lichen planus, rheumatoid arthritis, and some inherited skin disorders have also been associated with it.

A useful way to think about the condition is that the nail matrix, the tissue that makes the nail, may be affected by a disease or injury, producing a weaker nail as it grows. In that sense, onychorrhexis is often less a disease in itself than a visible sign of something else affecting nail formation.

Symptoms and appearance

The main sign is a series of vertical ridges running from the base of the nail toward the tip. The nail may also become brittle, split at the free edge, chip easily, or develop a rough texture. Some people notice the changes on one nail, while others have them on multiple nails. Pain is uncommon, but deeper splits can sometimes be uncomfortable.

Onychorrhexis is often confused with other nail problems, but it is distinct from pitting, which consists of small dents in the nail surface. That difference matters because pitting points more strongly toward other diagnoses such as psoriasis, while ridging and splitting point more toward onychorrhexis.

Diagnosis

Diagnosis is usually clinical, meaning a doctor can often identify it by looking at the nails and asking about symptoms, habits, and medical history. Because the condition can reflect an underlying disorder, the important task is not only naming the nail change but also finding the reason it is happening. A clinician may ask about diet, medications, hair or skin changes, fatigue, menstrual history, and exposure to chemicals or water.

In some cases, testing may be used to look for anemia, thyroid problems, fungal infection, or other systemic illness if the nail findings suggest more than simple cosmetic change. This is especially relevant when the nail changes are sudden, severe, painful, or accompanied by other symptoms

Treatment and care

Treatment depends on the cause. If an underlying condition such as iron deficiency, thyroid disease, or a fungal infection is found, addressing that problem may improve the nails over time. If the issue is related to irritants or habits, reducing exposure to soap, water, solvents, and trauma can help. Moisturizing the nails and protecting the hands with gloves during cleaning or dishwashing are practical steps that may reduce further damage.

Some sources mention supplements or topical approaches in selected cases, but the most important principle is to treat the cause rather than the ridges alone. Nails grow slowly, so improvement usually takes weeks to months even after the trigger is removed.

Prevention and outlook

Prevention focuses on gentle nail care and minimizing repeated injury. That includes avoiding harsh nail products, keeping nails trimmed, limiting contact with water and chemicals, and maintaining good nutrition. For people with chronic skin or medical conditions, controlling the underlying disease can reduce recurrence.

The outlook is generally good because onychorrhexis is often harmless and manageable. Still, it should not be ignored if the change is new, worsening, or accompanied by pain, discoloration, fatigue, or other symptoms. In those cases, the nails may be providing an early clue to a broader health issue.

Onychorrhexis is therefore best understood as a sign rather than a single disease: a visible pattern of ridging and brittleness that may be caused by aging, environment, habit, or illness. Written this way, it shows how the nails can reflect the health of both the skin and the body as a whole.

Posted on

Onychophosis

Onychophosis is a localized buildup of thickened keratinous skin in or around the nail sulcus, most often near the great toenail, and it can range from mildly annoying to very painful. It is commonly linked to pressure, friction, nail curvature, tight footwear, adjacent toe deformity, and poor nail trimming technique.

Onychophosis

Onychophosis, also called onychoclavus in some sources, is a hyperkeratotic condition affecting the nail folds or nail groove. Clinically, it is often described as thickened skin developing between the nail plate and the surrounding nail folds, and it may be mistaken for an ingrown toenail or fungal nail disease. Although it can occur in different toes, the hallux is particularly common, and some references note involvement of the first and fifth toes more frequently.

Pathology and Causes

The condition develops when repeated mechanical stress causes the skin to thicken as a protective response. A curved or involuted nail can compress the nail sulcus, while tight shoes or toe crowding increase lateral pressure and aggravate the process. Structural foot issues such as hallux valgus or other toe deformities may contribute by altering load distribution and increasing friction. In older adults, age-related nail changes and reduced self-care may also make onychophosis more common.

Clinical Features

Patients may report tenderness along the side of the nail, pain with shoe pressure, or discomfort when trimming the nail. In some cases, the skin thickening is obvious and in others it is subtle and easily missed. Severe cases may show periungual inflammation, erythema, or swelling, especially if the area has become repeatedly irritated. The key clinical point is that the pain may mimic an ingrown toenail even when the nail is not actually embedded in the skin.

Differential Diagnosis

Onychophosis should be distinguished from an ingrown toenail, which involves true penetration of the nail edge into soft tissue. It may also be confused with onychomycosis, periungual callus, or a corn adjacent to the nail fold. Careful inspection of the nail plate shape, the groove, and the surrounding skin usually helps separate these conditions. In practice, a patient may have both onychophosis and early ingrowing nail features at the same time.

Management

Management focuses on reducing pressure and removing the hyperkeratotic tissue. Conservative care usually includes careful debridement or reduction of the thickened skin, appropriate nail cutting, and avoidance of pressure from footwear. If nail curvature is contributing, regular professional nail care can help prevent recurrence. Addressing biomechanical factors such as toe crowding or hallux valgus may also reduce ongoing irritation.

Prevention and Prognosis

Prevention is largely mechanical: roomy shoes, good nail trimming technique, and early treatment of nail-edge pressure can all reduce recurrence. Because the disorder is driven by repeated friction or compression, symptoms often recur if the underlying cause is not corrected. The prognosis is generally good, especially when the area is treated early and footwear or nail-care habits are modified. In long-standing cases, ongoing podiatric care may be needed to keep the condition comfortable and prevent progression.

Onychophosis is a common but under-recognized cause of periungual pain and nail-fold hyperkeratosis. It is usually driven by chronic pressure, nail shape, footwear, or toe deformity rather than infection, which makes accurate diagnosis important for effective treatment. For patients, the most helpful approach is often a combination of local reduction of callus, better nail care, and correction of the mechanical cause.

Posted on

Overpronation in Runners

Overpronation in runners is best understood as a movement pattern, not a diagnosis in itself. A useful essay should explain what it is, why it matters for some runners, how it is assessed, and why treatment should be guided by symptoms rather than by foot type alone. Overpronation is a common gait pattern in which the foot rolls inward more than usual during stance. Pronation itself is normal and necessary for shock absorption, but when it is excessive or poorly controlled, it may alter load distribution through the foot, ankle, tibia, knee, and hip. In runners, this topic is often discussed because overpronation has been associated with a range of overuse injuries, including plantar fasciitis, shin splints, Achilles tendinopathy, runner’s knee, and IT band-related pain, although the relationship is not simple or perfectly predictive.

A strong essay should begin by clarifying that every runner pronates to some degree. The important distinction is between normal pronation, which helps the body adapt to impact, and excessive pronation, which may reflect reduced dynamic control or a structure that tends to collapse medially under load. This distinction matters because many runners are told that any visible inward roll is “bad,” when in fact pronation is part of efficient locomotion. The problem is not pronation itself, but whether the movement becomes excessive, prolonged, or associated with pain and tissue overload.

Biomechanical basis

From a biomechanical perspective, overpronation is usually described as excessive eversion of the rearfoot with concomitant midfoot collapse and internal rotation up the kinetic chain. As the foot stays in pronation longer than ideal, the lower limb may demonstrate greater tibial internal rotation, altered knee mechanics, and increased demand on muscles and passive tissues that resist collapse. Some sources also note that this may contribute to longer ground contact time and less efficient force transfer during running. For an academic essay, it is useful to frame these ideas as plausible mechanical pathways rather than universal causes of injury.

There is also an important structural-functional distinction. Flat arches, for example, are often associated with overpronation, but arch shape alone does not prove pathology or predict injury. Two runners with similar foot posture may tolerate load very differently depending on strength, training volume, recovery, footwear, and prior injury history. That is why modern clinical thinking tends to emphasize the whole runner rather than a single static observation.

Clinical signs

Common signs of overpronation include visible inward rolling of the ankle, flattening of the arch during weightbearing, inward knee drift during running, and wear on the inner edge of the shoe, especially at the heel and forefoot. Some people also notice their shoes tilting inward when placed on a flat surface. The “wet foot test” and shoe wear patterns can provide clues, but they are not definitive diagnostic tools. In a clinical setting, gait analysis, observation of running mechanics, and symptom correlation are much more informative than footprint shape alone.

A useful essay point is that overpronation is often overdiagnosed by casual observation. Many runners with pronounced pronation run comfortably and remain injury-free, while some injured runners have apparently neutral mechanics. This means the presence of overpronation should be interpreted as a potential contributing factor, not a stand-alone explanation for pain.

Injury associations

The injuries most often linked with overpronation are those involving repetitive load and poor tolerance to rotational or tensile stress. These include plantar fasciitis, medial tibial stress syndrome, patellofemoral pain, Achilles tendon disorders, bunions, and possibly hip or back symptoms in some individuals. However, the current message from contemporary running literature is that gait variables are only one part of a multifactorial injury model. Training errors, sudden mileage increases, poor recovery, muscle weakness, footwear mismatch, and prior injury history may matter more than pronation alone.

This is worth emphasizing in an essay because older models often treated pronation as a direct cause of injury and footwear as a correction. More recent guidance is more cautious: overpronation may increase stress in some runners, but it is not a reliable predictor of who will become injured. That more balanced view is clinically stronger and better supported by current discussions in running medicine.

Assessment and management

Assessment should start with symptoms and functional findings. If a runner is pain-free, overpronation usually does not need treatment. If pain is present, clinicians typically assess training load, footwear, mobility, strength, running economy, and observed gait before deciding on intervention. A treadmill gait analysis by a clinician or experienced running specialist is often more useful than a static foot test at home.

Management depends on whether the pronation pattern is contributing to symptoms. Practical options include load modification, calf and foot strengthening, hip and trunk control work, mobility exercises, and footwear review. Stability shoes may help some runners who overpronate, but shoe choice should be based on comfort, fit, and response to running, not just on foot type labels. Orthotic insoles can also be useful for some runners, particularly when symptoms persist or when a more targeted mechanical intervention is needed.

An effective conclusion should state that overpronation is common, often harmless, and only clinically important when it contributes to pain or overload. In runners, the focus should be on function, symptoms, and training context rather than on pronation as a moral or mechanical flaw. That framing reflects the current evidence better than the older idea that all overpronation must be corrected.

Posted on

What is the Os tibiale externum?

Os tibiale externum, more commonly called the accessory navicular, is a developmental variation of the medial navicular region rather than a true “extra” bone in the ordinary sense. It is usually located on the medial or dorsomedial aspect of the navicular and may be incorporated within, adjacent to, or connected with the posterior tibial tendon.

In clinical practice, the os tibiale externum matters because it is both common and often misunderstood. Many people have it without symptoms, but in some patients it becomes a significant source of medial midfoot pain, shoe irritation, altered mechanics, and posterior tibial tendon stress.

The term itself is a historical one, and “accessory navicular” is now used more often in modern medical writing. Radiology and orthopaedic sources describe it as an accessory ossicle near the navicular tuberosity, while older terminology reflects its position relative to the tibia and navicular region.

Anatomy and classification

The os tibiale externum is found at the medial side of the navicular, close to the insertion of the posterior tibial tendon. In some cases it appears as a separate ossicle, while in others it is a cartilage-connected or fused variant of the navicular tuberosity region.

A widely used clinical classification divides accessory naviculars into three types. Type I is a small sesamoid-like bone within the posterior tibial tendon, Type II is a larger ossicle linked to the navicular by a synchondrosis, and Type III is a fused or prominent navicular tuberosity that can represent a chronic union or remodeled variant.

This classification is useful because symptoms tend to correlate most strongly with Type II lesions, especially when the synchondrosis becomes irritated by load, footwear pressure, or traction from the posterior tibial tendon.

Development and prevalence

Accessory navicular bones are congenital variants, meaning they arise during development rather than from trauma. They represent an additional ossification center or an anatomic variant in the medial navicular region.

Prevalence estimates vary across populations, but the condition is common enough that it is regularly encountered in foot and ankle practice. Most cases are incidental findings on radiographs and never require active treatment, which is why recognition is important mainly when symptoms are present.

Clinical significance

The os tibiale externum becomes clinically relevant when it causes pain or contributes to dysfunction of the medial arch. Patients may report tenderness over the bony prominence, swelling, redness, pain with activity, and discomfort in enclosed shoes that rub against the medial midfoot.

Pain often develops because the accessory bone increases local pressure and can irritate the posterior tibial tendon or the surrounding soft tissue. In some patients, this may also be associated with flatfoot posture or posterior tibial tendon overload, which can amplify symptoms and make the area persistently irritated.

A useful way to think about it is this: the bone itself may be harmless, but the interface between bone, tendon, and shoe wear can become a mechanical pain generator. That is why symptom severity does not always match the size of the ossicle alone.

Diagnosis

Diagnosis begins with history and examination, especially when a patient presents with medial midfoot pain and a palpable prominence over the navicular tuberosity. Clinicians often look for localized tenderness, swelling, pain with resisted inversion or single-leg heel rise, and signs of posterior tibial tendon irritation.

Plain radiographs are usually sufficient to identify the accessory navicular and classify its type. Imaging may show a separate ossicle adjacent to the navicular, a synchondrosis in Type II lesions, or a fused prominence in Type III lesions; more advanced imaging may be helpful if tendon pathology or occult pain generators are suspected.

Differential diagnosis can include navicular stress injury, posterior tibial tendinopathy, plantar fasciopathy, tarsal coalition, and local soft-tissue bursitis. In practice, the combination of exam findings and imaging usually clarifies the diagnosis.

Treatment options

Most patients are treated conservatively first. Initial management commonly includes activity modification, temporary immobilization when symptoms are acute, footwear changes to reduce pressure, orthoses to support the medial arch, and anti-inflammatory strategies where appropriate.

Orthotic therapy is often used to reduce strain on the posterior tibial tendon and unload the painful prominence. Padding, wider shoes, and arch-supportive devices may help by decreasing direct shoe contact and improving midfoot mechanics.

Physiotherapy may be helpful when there is associated tendon overload, calf tightness, or altered foot function. Stretching, strengthening, and graded return to activity are commonly incorporated into management plans, especially when symptoms are linked to sport or prolonged standing.

Surgery is considered when pain persists despite well-conducted conservative care. Procedures may include excision of the accessory bone, contouring of the navicular prominence, and in selected cases repair or reattachment of the posterior tibial tendon, including approaches such as the Kidner procedure.

Surgical outcomes and concerns

Surgical treatment can be effective for carefully selected symptomatic cases, but procedure choice depends on the size and type of the accessory bone, tendon involvement, and the patient’s biomechanics. Contemporary surgical series show that Type II lesions are most often treated operatively because they are more likely to be symptomatic.

Postoperative recovery typically involves immobilization and a staged return to weight bearing and activity. As with any foot surgery, outcomes depend on accurate diagnosis, adequate offloading, and restoration of tendon function rather than removal of the bone alone.

Complications can include persistent pain, scar sensitivity, delayed return to sport, or ongoing posterior tibial tendon dysfunction if the underlying mechanics are not addressed. For that reason, surgery is usually reserved for patients whose symptoms are functionally limiting and resistant to conservative measures.

The os tibiale externum is best understood as a common accessory navicular variant with important biomechanical implications in a minority of patients. It is usually asymptomatic, but when it becomes painful, the problem is often a combination of bony prominence, synchondrosis irritation, footwear pressure, and posterior tibial tendon overload.

For clinicians, the key is to distinguish an incidental anatomic variant from a true pain source. For patients, the message is reassuring: most cases do not require surgery, and many symptomatic cases improve with load management, orthotic support, and targeted conservative treatment.

Posted on

Dealing with Onychomycosis of the Toenails

Onychomycosis of the toenails is a chronic fungal infection of the nail unit that commonly causes discoloration, thickening, brittle edges, subungual debris, and cosmetic concern. It is a frequent problem in clinical practice because toenails grow slowly, are often exposed to moist footwear environments, and are vulnerable to repeated trauma. Although the condition is not usually life-threatening, it can be uncomfortable, persistent, and socially distressing, and in higher-risk patients it may contribute to secondary complications such as skin breakdown or bacterial infection. Effective management depends on confirming the diagnosis, choosing treatment based on severity and organism type, and addressing factors that promote reinfection.

A major first step is ensuring that the nail change is truly fungal. Dystrophic nails can result from trauma, psoriasis, eczema, lichen planus, or age-related changes, and treating the wrong condition exposes the patient to unnecessary medication and delayed improvement. Because clinical appearance alone is not always reliable, confirmatory testing such as microscopy, culture, or other laboratory methods is often recommended before starting long courses of therapy. This is particularly important when the diagnosis is uncertain, when disease is extensive, or when systemic antifungal treatment is being considered.

The choice of treatment depends on the extent of disease, the number of nails involved, matrix involvement, patient preference, and comorbidities. For dermatophyte onychomycosis, oral terbinafine is widely regarded as the first-line therapy because it has high efficacy, relatively low relapse rates, and favorable cost-effectiveness. Typical treatment for toenails is 12 weeks. Oral itraconazole is another option, and fluconazole may be used in selected cases, especially when Candida species are involved or when other agents are not tolerated. Systemic therapy generally offers better cure rates than topical therapy, but it requires attention to contraindications, drug interactions, and potential hepatic or other adverse effects

Topical treatment has an important role, especially for mild or early disease. Topical agents such as efinaconazole, tavaborole, and ciclopirox can be useful when involvement is limited, when only a single nail is affected, or when the patient cannot take oral medication. However, topical therapy is usually less effective than oral treatment when used alone, largely because penetration through the nail plate is difficult. These agents often require prolonged daily use, sometimes for many months, and adherence can be challenging. For some patients, topical therapy is best used as an adjunct to oral treatment rather than as a standalone solution.

Mechanical care also matters. Regular trimming and debridement of thickened nails can reduce pressure, improve comfort, and allow topical medication to reach the nail better. In some cases, chemical or surgical nail avulsion may be considered, particularly when the nail is severely dystrophic or painful. Debridement does not cure the infection by itself, but it can improve functional outcomes and treatment tolerance. This is especially relevant in patients with very thick nails, where medication penetration is poor and routine footwear may become uncomfortable.

Patient education is a critical part of management because recurrence is common. The infection often persists in the surrounding skin, especially when tinea pedis is present, and reinfection from contaminated socks, shoes, or communal wet areas is frequent. Patients should be advised to treat any coexisting athlete’s foot, keep feet dry, change socks daily, use breathable footwear, and consider antifungal powders in shoes or on the feet when appropriate. Good nail hygiene, avoidance of sharing nail tools, and careful trimming of nails straight across can also help reduce ongoing trauma and spread

It is important to approach “natural” or home remedies cautiously. Some sources and anecdotal reports promote vinegar soaks, tea tree oil, or other household remedies, but these approaches generally have weaker evidence than prescription antifungal therapy and should not replace proven treatment in established onychomycosis. They may be used by some patients as adjuncts, but expectations should be realistic. In a patient with significant nail thickening or long-standing disease, relying on unproven remedies alone often leads to prolonged infection and frustration.

Certain patients need more careful assessment. Individuals with diabetes, peripheral vascular disease, neuropathy, or immunosuppression may be at higher risk of complications and may benefit from earlier systemic treatment and closer follow-up. In these groups, chronic nail infection can contribute to skin injury, discomfort with walking, and secondary bacterial problems. For patients taking multiple medications, checking interactions is essential before prescribing oral antifungals. In practice, the treatment plan should be individualized rather than applied as a one-size-fits-all approach.

Follow-up is another important part of care because improvement is slow. Toenails grow gradually, so visible normalization may take many months even after successful therapy. Patients should be counseled that the nail does not look normal immediately, and that treatment success is often measured by reduction in thickness, clearing from the proximal nail, and eventual healthy regrowth. This helps set expectations and improves adherence to long treatment courses.

Dealing with toenail onychomycosis requires a deliberate and evidence-based plan. Confirm the diagnosis, choose therapy based on severity and organism, consider oral terbinafine as the usual first-line option for dermatophyte infection, and use topical agents or debridement where appropriate. Equally important are preventive measures that reduce recurrence, including treating tinea pedis, keeping the feet dry, and maintaining nail hygiene. Because the condition is chronic and treatment response is slow, realistic expectations and consistent follow-up are essential for long-term success.

Posted on

Effect of Obesity on the Foot

Obesity affects the foot through both mechanical overload and biological changes, increasing pain, altering gait, and raising the risk of several common foot disorders. The strongest evidence links higher body mass with non-specific foot pain and chronic plantar heel pain, while also showing flatter foot posture, pronation, and higher plantar pressures during walking.The foot is uniquely vulnerable to excess body weight because it must absorb repeated ground-reaction forces during standing, walking, and running. In people with obesity, these forces rise across the heel, midfoot, forefoot, and supporting soft tissues, which can gradually exceed the tissue’s capacity to adapt. Over time, this can produce pain, fatigue, reduced mobility, and a cycle in which pain leads to less activity and further weight gain.

Mechanical loading

The most direct effect of obesity is increased load on foot structures. Research shows that higher body mass is associated with poor foot function, reduced inversion-eversion range of motion, flatter feet, and higher peak plantar pressures while walking. These changes matter because elevated pressure concentrates stress under the heel and forefoot, where plantar fasciitis, metatarsalgia, corns, calluses, and stress-related soft tissue pain often develop.

A useful way to think about this is that the foot behaves like a bridge: when the load rises and the support structures are already strained, small biomechanical changes can become symptomatic. In obese individuals, the arch may collapse more readily, and the plantar fascia and intrinsic foot muscles may need to work harder to stabilize the foot, which can worsen fatigue and discomfort.

Pain and function

Foot pain is one of the most consistent findings in the obesity literature. Increased fat mass is significantly associated with foot pain, and a systematic review found a strong association between increased BMI and both general foot pain and chronic plantar heel pain in non-athletic populations. The same review noted that evidence is less consistent for specific disorders such as hallux valgus, tendonitis, osteoarthritis, and flat foot, although these conditions still appear more frequently in many observational studies.

Functionally, this pain can reduce walking tolerance, limit exercise participation, and interfere with work and daily activities. That reduction in activity may create a feedback loop: less movement contributes to deconditioning, which then makes weight-bearing tasks feel harder and increases the relative burden on the feet.

Common foot disorders

Several foot and ankle problems are more common or more severe in people with obesity. Tendinitis is one of the clearer associations in orthopaedic studies, and plantar fasciitis is frequently reported because the plantar fascia is exposed to prolonged strain from increased body mass. Osteoarthritic symptoms may also worsen because greater load accelerates wear across the joints of the foot and ankle.

Obesity is also linked with collapsed arches or planus posture, pronation, bunions, hammertoes, calluses, and metatarsal overload, although the strength of evidence varies by condition. In addition, obese individuals may be more prone to skin problems such as blisters, fungal infection, maceration, and slow-healing sores, especially when footwear fit is poor or sweating is increased. These complications are not only uncomfortable; they can raise the risk of secondary infection and further reduce mobility.

Biomechanics and posture

Obesity can alter lower-limb mechanics beyond the foot itself. Increased mass often changes standing posture, walking pattern, and the distribution of forces through the ankle, subtalar joint, midfoot, and forefoot. Some studies suggest greater calcaneal eversion and more pronated movement patterns, which may help explain why the medial arch and plantar fascia are commonly affected.

These biomechanical shifts can be especially important in people who already have limited ankle dorsiflexion, weak calf function, or pre-existing foot deformity. When the foot has less capacity to dissipate force, repetitive loading can provoke inflammation, discomfort, and compensatory movement patterns that increase the risk of injury elsewhere in the kinetic chain.

Clinical implications

From a clinical perspective, obesity should prompt careful assessment of both symptoms and mechanics. Examination should include pain location, footwear, foot posture, plantar pressure-related lesions, range of motion, and walking pattern, because the source of pain may be multifactorial rather than purely structural. Conservative management often involves load reduction, supportive footwear, orthoses when indicated, activity modification, and treatment of skin or soft tissue complications.

Weight reduction may plausibly reduce mechanical stress, but the review literature notes that direct evidence for symptom improvement after weight loss is still limited. Even so, improving load tolerance through a combination of exercise, footwear, and targeted treatment is likely to help many patients, particularly those with plantar heel pain or midfoot overload.

Obesity has a substantial impact on the foot because it increases mechanical load, changes gait and posture, and raises the likelihood of pain, plantar heel symptoms, and pressure-related skin problems. The result is often reduced function and a downward spiral of inactivity and worsening symptoms. For podiatric management, the key is to address both the extra load and the biomechanical consequences, rather than treating the foot in isolation.

Posted on

Nocturnal Leg Cramps

Nocturnal leg cramps are sudden, painful, involuntary contractions of the calf or foot muscles that typically occur at night and can disrupt sleep. They are common, especially with increasing age, and most cases are benign and idiopathic, though they may also be associated with dehydration, muscle fatigue, pregnancy, medications, and certain medical conditions. Nocturnal leg cramps are one of the most frequent causes of sleep disturbance in otherwise healthy adults. They usually affect the calf, but the foot or thigh may also be involved, and the pain can be intense enough to wake a person from sleep. Episodes may last from a few seconds to several minutes, and the muscle may feel hard or knotted during the cramp.

Although often dismissed as a minor complaint, recurrent nocturnal leg cramps can have a meaningful impact on sleep quality, daytime functioning, and overall wellbeing. In older adults, they are particularly common and may become a persistent quality-of-life issue.

Clinical Features

The defining feature of nocturnal leg cramps is a sudden, involuntary, painful contraction of a leg muscle during sleep or rest. Patients often describe the muscle as tightening or locking, with visible or palpable firmness in the affected area. The cramp may resolve spontaneously, but residual soreness can persist afterward.

These cramps are distinct from restless legs syndrome, periodic limb movements, or generalized muscle aches. In nocturnal leg cramps, the pain is focal and the contraction is real and forceful, rather than simply an urge to move the legs. That distinction matters because the underlying causes and management strategies differ

Causes and Risk Factors

In many cases, no specific cause is identified. Age is one of the strongest risk factors, and nocturnal leg cramps become more common in older adults. Pregnancy, especially later in gestation, is another well-recognized association.

Secondary causes and associations include dehydration, muscle fatigue, prolonged exercise, certain medicines such as diuretics and statins, and chronic health conditions including kidney disease, diabetic neuropathy, peripheral vascular disease, thyroid disorders, and neurologic disease. Some cases may also be linked to poor physical conditioning, muscle shortening, or electrolyte-related factors, although the exact mechanism remains uncertain.

Pathophysiology

The exact mechanism of nocturnal leg cramps is not fully understood. One leading idea is that they reflect hyperexcitability of the motor system or altered neuromuscular control, rather than a simple electrolyte deficiency. This helps explain why many patients have cramps despite normal blood tests and why correcting electrolytes does not reliably resolve symptoms.

Another practical observation is that cramps often happen when the calf is in a shortened position during sleep. That is one reason stretching may help, even though the evidence for stretching as a preventive strategy is mixed. The likely explanation is mechanical and neuromuscular rather than purely biochemical

Diagnosis

Diagnosis is usually clinical and based on the history. A typical story includes sudden nighttime calf pain, visible muscle tightening, and relief after stretching, standing, or massage. In many patients, no extensive testing is required if the presentation is classic and there are no alarming features.

Further evaluation is appropriate if cramps are frequent, severe, atypical, or associated with numbness, weakness, swelling, claudication, or systemic illness. In those cases, clinicians may look for medication causes, vascular disease, neuropathy, renal disease, endocrine disorders, or other contributing problems.

Management

First-line management is conservative. Stretching the calf muscles, massaging the cramp, standing up, and putting weight on the affected leg may help relieve an episode. Regular calf-stretching before bed is commonly advised and may reduce frequency in some people, although study results are inconsistent.

Addressing possible triggers is also important. This includes reviewing medications, improving hydration when appropriate, reducing excessive muscle fatigue, and treating any underlying disorder that may be contributing. For patients whose cramps interfere with sleep, clinicians may consider additional therapies after weighing benefit and risk.

Drug Therapy

Drug treatment is not straightforward because the evidence is limited and adverse effects matter. Quinine can reduce cramps, but it is no longer recommended routinely because of potentially serious toxicity, including thrombocytopenia, hypersensitivity reactions, and QT prolongation.

Other agents such as calcium channel blockers or vitamin B complex have shown limited or short-term benefit in some studies, while magnesium has not consistently demonstrated clear benefit for idiopathic nocturnal leg cramps. Overall, medications should be considered selectively rather than as standard treatment for everyone.

Nocturnal leg cramps are common, painful, and often disruptive, but they are usually benign. The condition is best approached through careful clinical assessment, attention to risk factors and secondary causes, and a trial of conservative measures such as stretching and massage.

For many patients, reassurance is valuable because the cramps are distressing but not necessarily dangerous. When symptoms are frequent or severe, the goal should be to identify any underlying cause, reduce nighttime episodes, and protect sleep quality without exposing patients to unnecessary medication risk.

Posted on

Night splints for plantar fasciitis

Night splints are a useful conservative treatment for plantar fasciitis, especially for patients who wake with strong first-step pain, but their benefit is usually greatest in the short term rather than as a stand-alone long-term cure.

Plantar fasciitis is one of the most common causes of plantar heel pain in active and sedentary adults, and it typically presents with sharp pain on the first steps in the morning or after periods of rest. Night splints are designed to reduce that familiar morning pain by holding the ankle in dorsiflexion and keeping the plantar fascia under a gentle stretch overnight. In practice, they are most often used for patients whose symptoms persist despite basic measures such as stretching, activity adjustment, and supportive shoes.

How Night Splints Work

The underlying idea is simple: during sleep, the foot tends to rest in plantarflexion, which allows the plantar fascia and calf complex to tighten. When the patient stands up in the morning, that shortened tissue is suddenly loaded, contributing to the classic “first-step” pain of plantar fasciitis. By maintaining a sustained stretch through the night, the splint may reduce this tightening and make morning steps less painful.

This mechanism also makes night splints conceptually similar to prolonged stretching, but with the advantage that the stretch is passive and occurs during rest. Some splints are bulkier posterior boot designs, while others are lower-profile dorsal strap devices; both aim to hold the ankle in dorsiflexion, but comfort and adherence can differ. The best device is often the one the patient will actually tolerate consistently.

Evidence and Effectiveness

The evidence supports night splints as a reasonable option, but not as a guaranteed solution. A clinical trial reported significant short-term relief when a night splint was added to conservative management, although it did not reduce recurrence at two years. A separate review in primary care literature noted that custom-made night splints may help, while prefabricated options had less convincing benefit. More recent clinical practice guidance recommends a 1- to 3-month night splint program for patients who consistently have first-step morning pain.

That said, the literature is not uniformly enthusiastic. Some reports suggest night splints improve symptoms mainly while they are being used, with less clear long-term superiority over exercise-based care alone. For an academic essay, this tension is important: night splints are evidence-informed, but their role is best described as adjunctive and symptom-focused rather than curative.

Clinical Use

Night splints are usually prescribed for patients with persistent plantar fasciitis, especially those with pronounced morning pain or symptoms lasting more than several weeks. They are commonly introduced after or alongside stretching programs, calf flexibility work, and advice on reducing aggravating loads. The usual course is about 1 to 3 months, with reassessment if symptoms fail to improve.

Comfort and adherence matter a great deal. Instructions for use commonly emphasize adjusting straps so the device is snug but not overly tight, and reducing tension if numbness, tingling, or other discomfort occurs. Some clinicians advise a gradual break-in period, because immediate overnight wear may be uncomfortable for some patients. If used poorly or inconsistently, even a theoretically effective treatment may fail.

Advantages and Limitations

The main advantages of night splints are their non-invasive nature, low cost relative to procedural interventions, and ability to target the troublesome morning pain pattern. They can be especially attractive for patients who want to avoid injections or surgery while still doing something active about their symptoms. Because they work passively, they may also suit patients who struggle to keep up with frequent stretching routines.

The limitations are equally important. Night splints can be uncomfortable, interfere with sleep, and reduce adherence, particularly if the splint is bulky or tightly fitted. Evidence also suggests that their effect may be temporary, and they should not be presented as a definitive solution for all cases of plantar fasciitis. In severe or atypical cases, clinicians must also consider other diagnoses such as stress injury, nerve entrapment, or systemic inflammatory disease.

Place in Management

A balanced management model places night splints within a broader conservative plan. That plan usually includes calf and plantar fascia stretching, load management, footwear advice, and possibly orthoses or other adjunctive treatment depending on the clinical picture. For runners or highly active patients, this integrated approach is especially relevant because symptoms often reflect both tissue irritability and mechanical overload.

From a podiatric perspective, the strongest argument for night splints is that they address a very specific symptom pattern: first-step morning pain. They are less compelling as a universal treatment for every case of heel pain. Therefore, the most accurate academic conclusion is that night splints are a practical, evidence-supported adjunct that may reduce symptoms and improve function, particularly in the short term, but they work best when combined with other conservative measures.

Night splints remain a clinically useful option for plantar fasciitis because they target the overnight shortening that contributes to morning heel pain. The evidence supports their use as part of conservative care, especially in patients with persistent first-step pain, but their benefits are strongest when combined with stretching and other load-reducing strategies. In an essay, the most defensible position is that they are helpful, low-risk, and worth trialling in selected patients, while acknowledging variable comfort and limited long-term superiority.

Posted on

New Balance running shoes

New Balance running shoes are best understood as a broad, performance-led lineup that spans daily trainers, stability models, trail shoes, and race-day supershoes. The brand’s appeal comes from combining cushioning, support, and fit variety with enough range to suit beginners, mileage-focused runners, and competitive athletes alike.

Brand identity

New Balance has long been associated with accommodating fits and practical running performance, especially through its wider size and width options. Its running line evolved from classic numbered models into a modern system built around distinct performance foams and shoe categories, giving runners clearer choices based on use case. That mix of heritage and innovation is one reason the brand remains relevant across recreational and serious running markets

Core technologies

The company’s current running shoes are anchored by a few major midsole platforms. Fresh Foam and Fresh Foam X are positioned as soft, comfortable cushioning systems for daily training and all-day wear, while FuelCell is the more responsive, propulsive option aimed at speed, racing, and lively training runs. New Balance also uses stability features such as medial posts and T-BEAM in some models, plus trail-oriented elements like Vibram outsoles and GORE-TEX uppers in selected shoes.

Model ranges

The neutral daily-trainer segment is led by models such as the 880 and 1080, which are commonly described as reliable high-mileage shoes with comfort-focused rides. The 1080 is presented as a plush but responsive premium trainer, while the 880 is framed as a stable, balanced workhorse for everyday running. For runners needing support, the 860 provides a more structured option with stability-oriented design cues.

At the performance end, New Balance offers FuelCell-based shoes that emphasize speed and rebound. The Rebel line targets lightweight training and faster workouts, while carbon-plated options such as the SuperComp and Elite series are built for race-day efficiency and marathon-level performance. This tiered structure makes the lineup easy to navigate if you know whether you want comfort, support, or race pace

Strengths

One of the strongest points of New Balance running shoes is versatility. The brand produces shoes for easy runs, long runs, tempo sessions, trail running, and racing, so many runners can stay within the same ecosystem across different training needs. Comfort is another recurring strength, with Fresh Foam models especially marketed for soft landings and pressure dispersion.

Fit is also a major advantage. New Balance has built a reputation for offering more accommodating sizing and width choices than many competitors, which is especially valuable for runners who struggle with narrow toe boxes or restrictive uppers. For a lot of runners, that practical fit advantage can matter as much as midsole technology.

Limitations

The main weakness is that the range can feel confusing because many models overlap in purpose. A runner comparing the 880, 1080, More, Rebel, and SuperComp lines may find the differences subtle unless they already understand foam density, stack height, and geometry. Price is another consideration, since premium plated and top-end cushioning shoes often sit at the higher end of the market

Some third-party review sites also show mixed consumer sentiment toward New Balance as a brand, though that reflects broader purchasing and service experiences rather than running performance alone. As with most shoe brands, the best New Balance model depends heavily on the runner’s gait, volume, terrain, and cushioning preference.

Overall assessment

As a running-shoe brand, New Balance stands out for combining comfort, fit options, and a genuinely wide performance spectrum. It is especially strong for runners who want dependable daily trainers, stable mileage shoes, or modern super-shoe performance without leaving the brand ecosystem. If you want a strong general-purpose brand with clear options for neutral, stability, trail, and race use, New Balance is one of the most complete choices on the market.

Posted on

The Neuropad

The assessment of the diabetic foot is fundamentally aimed at identifying patients at risk of ulceration, infection, and amputation before tissue breakdown occurs. Neuropathy is central to that process, because loss of protective sensation, impaired autonomic function, and altered biomechanics all increase plantar loading and reduce the foot’s ability to defend itself. Neuropad has attracted interest because it offers a simple bedside method of detecting one important component of diabetic neuropathy: sudomotor dysfunction. By measuring the skin’s ability to change colour in response to sweat, it provides an indirect marker of sympathetic cholinergic small-fibre function.

Neuropad is applied to the plantar surface of the foot, typically over the great toe or forefoot region, and the result is read after a set period according to the degree and speed of colour change from blue to pink. In healthy skin, the plaster changes colour relatively quickly because sweating is intact. When the colour change is delayed, incomplete, or absent, this suggests reduced sweating and therefore autonomic neuropathy. This mechanism is clinically relevant because autonomic neuropathy contributes to dry, brittle skin and higher vulnerability to cracking and ulceration, especially in patients with diabetes who already have pressure-related risk factors.

The main strength of Neuropad is practicality. It is non-invasive, easy to perform, inexpensive, and does not require advanced equipment or specialised neurophysiology training. These features make it attractive in primary care, podiatry, and other outpatient settings where rapid risk stratification is needed. A meta-analysis of 18 diagnostic studies involving 3470 participants found average sensitivity of 86% and specificity of 65%, supporting its role as a triage test that can help rule out the “foot at risk” when negative. The same review concluded that patients with a positive result should be referred for more specialised assessment to establish a definite diagnosis.

A further advantage is that Neuropad appears to assess small-fibre dysfunction relatively well. In a comparative study of diabetic patients, its accuracy was stronger against corneal nerve fibre length, a marker of small-fibre damage, than against traditional large-fibre tests such as neuropathy disability score, vibration perception threshold, and motor nerve conduction velocity. This matters because early diabetic neuropathy often involves small fibres first, including autonomic fibres, before conventional bedside tests become clearly abnormal. In that sense, Neuropad may detect an earlier stage of neuropathic change than routine large-fibre-focused screening alone.

There is also evidence linking Neuropad to clinical ulcer risk. In one study of type 2 diabetes, the time to complete colour change performed better than 10 g monofilament testing in predicting diabetic foot ulcer risk, with an area under the ROC curve of about 0.8 and a suggested cut-off around 22.25 minutes. This supports the idea that sudomotor impairment is not merely a laboratory marker but has practical value in identifying patients more likely to develop foot complications. Another study in patients with diabetic foot ulceration found that Neuropad was a reliable and easy-to-use test for autonomic neuropathy, which was associated with greater ulceration and amputation risk.

However, Neuropad has important limitations. Its specificity is only moderate, so a positive result does not confirm neuropathy on its own and may produce false positives. It should therefore be interpreted within a full diabetic foot assessment that includes history, inspection, vascular assessment, monofilament or other sensory testing, footwear review, and biomechanical evaluation. The test also does not replace formal neurological examination, and the evidence base has been criticised for risk of bias and uncertainty about patient-important outcomes such as ulcer prevention, cost-effectiveness, and impact on long-term management. For these reasons, Neuropad is best viewed as an adjunctive screening tool rather than a definitive diagnostic test.

In clinical practice, the most defensible use of Neuropad is as part of a layered risk-assessment strategy. A negative result can add reassurance when the overall clinical picture suggests low risk, while an abnormal result can strengthen the case for closer surveillance, patient education, pressure management, and referral for comprehensive neuropathy evaluation. In a podiatry or diabetes clinic, this may be especially useful where there is concern about early autonomic involvement, dry skin, recurrent callus, or unexplained fissuring, all of which can precede ulceration. Its simplicity also makes it attractive for self-testing and community-based screening, although that should not substitute for professional foot surveillance.

Overall, Neuropad has a clear place in the assessment of the diabetic foot as a simple indicator of sudomotor dysfunction and small-fibre neuropathy. Its best role is as a screening or triage tool that helps identify patients needing more detailed evaluation, rather than as a standalone diagnostic endpoint. In an era where diabetic foot complications remain a major cause of morbidity, a test that is quick, non-invasive, and reasonably sensitive can be clinically valuable if used appropriately within a broader assessment framework.[